EIF4E and lymphoma: Interestingly, ribavirin cooperated with an HSP90 inhibitor to suppress tumor growth (patient-derived lymphoma xenograft or xenografts of established double/triple-hit B-cell lines) potentially since HSP90 binds to eIF4E and may be required to maintain or enhance its activity.